- Home
- SWX vs LEGN Comparison
SWX vs LEGN Comparison
Compare SWX & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWX
- LEGN
- Stock Information
- Founded
- SWX 1931
- LEGN 2014
- Country
- SWX United States
- LEGN United States
- Employees
- SWX N/A
- LEGN N/A
- Industry
- SWX Oil & Gas Production
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- SWX Utilities
- LEGN Health Care
- Exchange
- SWX Nasdaq
- LEGN Nasdaq
- Market Cap
- SWX 5.6B
- LEGN 6.3B
- IPO Year
- SWX N/A
- LEGN 2020
- Fundamental
- Price
- SWX $78.35
- LEGN $31.46
- Analyst Decision
- SWX Strong Buy
- LEGN Strong Buy
- Analyst Count
- SWX 3
- LEGN 12
- Target Price
- SWX $82.33
- LEGN $73.36
- AVG Volume (30 Days)
- SWX 425.2K
- LEGN 1.2M
- Earning Date
- SWX 11-05-2025
- LEGN 11-11-2025
- Dividend Yield
- SWX 3.16%
- LEGN N/A
- EPS Growth
- SWX 6.32
- LEGN N/A
- EPS
- SWX 2.69
- LEGN N/A
- Revenue
- SWX $4,766,188,000.00
- LEGN $796,838,000.00
- Revenue This Year
- SWX N/A
- LEGN $69.31
- Revenue Next Year
- SWX N/A
- LEGN $52.73
- P/E Ratio
- SWX $29.17
- LEGN N/A
- Revenue Growth
- SWX N/A
- LEGN 74.75
- 52 Week Low
- SWX $64.69
- LEGN $27.34
- 52 Week High
- SWX $80.54
- LEGN $51.77
- Technical
- Relative Strength Index (RSI)
- SWX 51.80
- LEGN 31.45
- Support Level
- SWX $77.93
- LEGN $32.02
- Resistance Level
- SWX $79.21
- LEGN $32.62
- Average True Range (ATR)
- SWX 1.14
- LEGN 1.02
- MACD
- SWX -0.05
- LEGN -0.09
- Stochastic Oscillator
- SWX 52.90
- LEGN 6.87
About SWX Southwest Gas Holdings Inc. (DE)
Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.